Annual ROE
-130.43%
-349.35%-159.58%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual return on equity is currently -130.43%, with the most recent change of -349.35% (-159.58%) on 31 December 2023. During the last 3 years, it has fallen by -202.86% (-280.08%).ACRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-128.94%
-12.84%-11.06%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly return on equity is currently -128.94%, with the most recent change of -12.84% (-11.06%) on 31 December 2023. Over the past year, it has dropped by -12.84% (-11.06%).ACRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -159.6% | -11.1% |
| 3 y3 years | -280.1% | -244.7% |
| 5 y5 years | +88.2% | -131.6% |
ACRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -159.6% | -104.3% |
AcelRx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -130.43%(-159.6%) | -128.94%(+11.1%) |
| Sept 2023 | - | -116.10%(-7.3%) |
| June 2023 | - | -125.22%(-130.2%) |
| Mar 2023 | - | 415.09%(-86.1%) |
| Dec 2022 | 218.92%(+123.9%) | 2978.36%(-312.1%) |
| Sept 2022 | - | -1404.01%(+545.6%) |
| June 2022 | - | -217.49%(-339.2%) |
| Mar 2022 | - | 90.92%(-7.9%) |
| Dec 2021 | 97.79%(+35.0%) | 98.72%(+10.8%) |
| Sept 2021 | - | 89.10%(+7.5%) |
| June 2021 | - | 82.88%(+24.7%) |
| Mar 2021 | - | 66.47%(-5.8%) |
| Dec 2020 | 72.43%(-43.7%) | 70.53%(-17.5%) |
| Sept 2020 | - | 85.49%(-20.4%) |
| June 2020 | - | 107.37%(-30.6%) |
| Mar 2020 | - | 154.80%(-30.2%) |
| Dec 2019 | 128.54%(-111.6%) | 221.83%(-45.7%) |
| Sept 2019 | - | 408.30%(+19.5%) |
| June 2019 | - | 341.57%(+56.8%) |
| Mar 2019 | - | 217.86%(+49.5%) |
| Dec 2018 | -1108.61%(-885.8%) | 145.77%(+39.4%) |
| Sept 2018 | - | 104.56%(-5.6%) |
| June 2018 | - | 110.73%(-15.4%) |
| Mar 2018 | - | 130.88%(-25.0%) |
| Dec 2017 | 141.08%(-145.4%) | 174.46%(-26.1%) |
| Sept 2017 | - | 236.09%(-36.6%) |
| June 2017 | - | 372.62%(-123.8%) |
| Mar 2017 | - | -1567.90%(+394.0%) |
| Dec 2016 | -310.75% | -317.38%(+63.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | -194.28%(+102.3%) |
| June 2016 | - | -96.05%(+29.6%) |
| Mar 2016 | - | -74.14%(+18.0%) |
| Dec 2015 | -61.17%(+9.9%) | -62.82%(-0.0%) |
| Sept 2015 | - | -62.84%(-7.6%) |
| June 2015 | - | -68.01%(+7.8%) |
| Mar 2015 | - | -63.10%(+13.3%) |
| Dec 2014 | -55.67%(+27.2%) | -55.68%(+1826.6%) |
| Sept 2014 | - | -2.89%(-89.1%) |
| June 2014 | - | -26.53%(-42.6%) |
| Mar 2014 | - | -46.25%(-25.7%) |
| Dec 2013 | -43.78%(-66.3%) | -62.25%(-72.4%) |
| Sept 2013 | - | -225.47%(-36.8%) |
| June 2013 | - | -356.76%(+35.4%) |
| Mar 2013 | - | -263.56%(+10.0%) |
| Dec 2012 | -130.03%(+13.0%) | -239.52%(-3.0%) |
| Sept 2012 | - | -246.92%(+64.5%) |
| June 2012 | - | -150.13%(+40.6%) |
| Mar 2012 | - | -106.75%(+34.4%) |
| Dec 2011 | -115.07%(-628.6%) | -79.45%(-79.5%) |
| Sept 2011 | - | -386.88%(-120.9%) |
| June 2011 | - | 1848.25%(+1307.8%) |
| Mar 2011 | - | 131.29%(+191.3%) |
| Dec 2010 | 21.77%(-42.7%) | 45.07%(-21.2%) |
| Sept 2010 | - | 57.22%(+177.8%) |
| June 2010 | - | 20.60%(+48.0%) |
| Mar 2010 | - | 13.92%(+99.4%) |
| Dec 2009 | 37.96%(-38.8%) | 6.98% |
| Dec 2008 | 61.98% | - |
FAQ
- What is AcelRx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals annual ROE year-on-year change?
- What is AcelRx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly ROE year-on-year change?
What is AcelRx Pharmaceuticals annual return on equity?
The current annual ROE of ACRX is -130.43%
What is the all time high annual ROE for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual return on equity is 218.92%
What is AcelRx Pharmaceuticals annual ROE year-on-year change?
Over the past year, ACRX annual return on equity has changed by -349.35% (-159.58%)
What is AcelRx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ACRX is -128.94%
What is the all time high quarterly ROE for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly return on equity is 2978.36%
What is AcelRx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ACRX quarterly return on equity has changed by -12.84% (-11.06%)